Session 13: Medical Cannabis Use in Older Adults

References:

Maida V, Shi RB, Fazzari FGT, Zomparelli L. Topical cannabis-based medicines – A novel paradigm and treatment for non-uremic calciphylaxis leg ulcers: An open label trial [published online ahead of print, 2020 Sep 2]. Int Wound J. 2020;17(5):1508-1516. doi:10.1111/iwj.13484

Maida V, Corban J. Topical Medical Cannabis: A New Treatment for Wound Pain-Three Cases of Pyoderma Gangrenosum. J Pain Symptom Manage. 2017;54(5):732-736. doi:10.1016/j.jpainsymman.2017.06.005

Reynolds IR, Fixen DR, Parnes BL, et al. Characteristics and Patterns of Marijuana Use in Community-Dwelling Older Adults. J Am Geriatr Soc. 2018;66(11):2167-2171. doi:10.1111/jgs.15507

Katz I, Katz D, Shoenfeld Y, Porat-Katz BS. Clinical Evidence for Utilizing Cannabinoids in the Elderly. Isr Med Assoc J. 2017;19(2):71-75.

Lloyd SL, Striley CW. Marijuana Use Among Adults 50 Years or Older in the 21st Century. Gerontol Geriatr Med. 2018;4:2333721418781668. Published 2018 Jun 21. doi:10.1177/2333721418781668

Briscoe J, Casarett D. Medical Marijuana Use in Older Adults. J Am Geriatr Soc. 2018;66(5):859-863. doi:10.1111/jgs.15346

Allan GM, Ramji J, Perry D, et al. Simplified guideline for prescribing medical cannabinoids in primary care. Can Fam Physician. 2018;64(2):111-120.

Koppel BS, Brust JC, Fife T, et al. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014;82(17):1556-1563. doi:10.1212/WNL.0000000000000363

Allan GM, Finley CR, Ton J, et al. Systematic review of systematic reviews for medical cannabinoids: Pain, nausea and vomiting, spasticity, and harms. Can Fam Physician. 2018;64(2):e78-e94.

Fraser GA. The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neurosci Ther. 2009;15(1):84-88. doi:10.1111/j.1755-5949.2008.00071.x

Articles to Read